A1CNow System by PTS Diagnostics | 20, 40, or 24/Case Test HbA1c Kit

Description A1CNow CLIA-Waived HbA1c Test Kit | 20, 40, or 24/Case Test Professional System A1CNow test by PTS Diagnostics is widely trusted. CLIA-waived HbA1c testing system designed to help diagnose and monitor Type 1 and Type 2 diabetes with rapid, point-of-care accuracy. Also known as glycated hemoglobin, hemoglobin A1c, or HbA1c, this professional blood test provides a reliable snapshot of a patient’s average blood glucose levels over the past 2 to 3 months. With 20- and 40-test kit options available, A1CNow supports efficient in-office diabetes monitoring and streamlined patient care in clinical, physician, and remote healthcare settings. This CLIA-waived A1C test kit measures the percentage of glycated hemoglobin (HbA1c) present in the blood, providing an accurate assessment of long-term glucose control. Because HbA1c reflects average blood sugar levels over approximately 8–12 weeks. It is considered the clinical standard for monitoring diabetes progression and treatment effectiveness. Elevated A1C levels may indicate inadequate glycemic control and increased risk for diabetes-related complications, making routine 3–6 month testing an essential component of patient care. The A1CNow Professional System, designed for fast, on-the-spot HbA1c results in clinical and point-of-care environments. Using a simple fingerstick (lancet) blood sample, the device delivers lab-comparable results in approximately 5 minutes—no fasting required. Its compact, maintenance-free design allows healthcare providers to streamline diabetes screening and follow-up appointments while improving patient compliance and real-time treatment decisions. Key Benefits of the 40-Test HbA1c Kit Accurately measures glycated hemoglobin (HbA1c) for reliable long-term blood glucose assessment Supports ADA-recommended 3–6 month diabetes monitoring protocols for ongoing patient management Ideal for clinics, physician offices, pharmacies, health programs, and community screening settings 40-test capacity ensures consistent quarterly patient follow-up without supply interruptions 11-month expiration date from purchase allows predictable inventory control and reduced product waste Enables improved glycemic control tracking, treatment adjustment, and diabetes care optimization For healthcare providers performing routine quarterly or biannual HbA1c testing, the 40-test A1CNow kit offers a practical advantage in efficiency and inventory planning. With greater test capacity and an 11-month expiration date from purchase, clinics can better align supply with recommended 3–6 month monitoring schedules while minimizing reorder frequency and product waste. A1CNow HbA1c Test Kit FAQs What does the test measure? The A1C Now test measures hemoglobin A1c (HbA1c). Which reflects average blood glucose levels over the past two to three months. Healthcare providers use this value to assess long-term diabetes control and treatment effectiveness. Who can use the A1C Now HbA1c test kit? Adults diagnosed with diabetes or individuals monitoring glucose control may use the A1C Now test kit under healthcare provider guidance. Commonly used in clinical, physician office, pharmacy, and point-of-care settings. How quickly does the A1C test provide results? The A1C Now system delivers results in approximately 5 minutes. Using a simple fingerstick blood sample, eliminating the need for laboratory processing. Is the A1C Now test for home use or professional use? The A1C Now Professional System is primarily designed for healthcare providers in clinical environments. Home use may be recommended by a physician depending on individual care plans. How often should HbA1c levels be checked? Most healthcare providers recommend HbA1c testing every 3–6 months, depending on diabetes type, treatment stability, and individual health goals. The A1CNow Professional HbA1c Test Kit provides healthcare providers with a reliable, CLIA-waived solution for fast, accurate diabetes monitoring at the point of care. Whether selecting the 20-test or 40-test configuration, practices can confidently support ADA-recommended 3–6 month HbA1c testing protocols while improving workflow efficiency and patient follow-up consistency. With rapid 5-minute results and dependable performance, A1CNow remains a trusted choice for streamlined diabetes management and long-term glycemic control assessment.